News and Events
Keep Up with the Latest from Team Exela
of 8.4% Sodium Bicarbonate Injection, USP, 50 mEq/50 mL due to Defective Crimp...
We have become aware that individuals are falsely claiming to represent our company...
Exela Pharma Sciences, LLC Issues Voluntary Nationwide Recall of 8.4% Sodium Bicarbonate Injection,...
LENOIR - The Exela Pharma Sciences Inpatient Pharmacy will be a part of...
Lenoir, NC February 6, 2023 – Exela Pharma Sciences, LLC (“Exela”) has commenced...
Exela Pharma Sciences, LLC Expands and Issues Voluntary Nationwide Recall of Sodium Bicarbonate...
CHARLOTTE, N.C., September 8, 2021 ─ Premier Inc. (NASDAQ: PINC), a leading technology-driven healthcare improvement company,...
Exela Pharma Sciences believes that providing medicines to alleviate human pain and suffering...